OncoTargets and Therapy · 2018 · 26 citations · 34 references
MedicineCell BiologyOncologyMetastasisMolecular OncologyNeoplasiaCancer Cell SignalingCancer Molecular PathologyEsophageal CancerMalignant NeoplasmsOncogenic Signaling PathwaysSquamous Cell CarcinomaCancer Signaling PathwaysEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersMesenchymal TransitionPhosphatidylinositol 3-Kinase-akt PathwayPi3k-akt Signaling PathwayPrognostic Biomarker DiscoveryTumor Cell Proliferation
BACKGROUND: Centrosomal protein 55 (CEP55) is an important prognostic biomarker that plays an essential role in the proliferation, migration and invasion of multiple tumors. We aimed to investigate the prognostic value of CEP55 in pN0 esophageal squamous cell carcinoma (ESCC) and explore its biological function in ESCC cells. METHODS: We used immunohistochemistry and Western blot analysis to detect the expression of CEP55 in ESCC. Furthermore, both in vitro and in vivo assays were used to determine the effect of CEP55 on malignant behavior in ESCC cells. RESULTS: As expected, we found that CEP55 was overexpressed in ESCC. Univariate and multivariate analyses demonstrated that patients with CEP55 overexpression had a poor prognosis. Additionally, the abilities of proliferation, migration and invasion of cells, as well as the epithelial-mesenchymal transition markers, were all altered with the changed CEP55 expression levels in ESCC cells. Further study elucidated that CEP55 facilitated ESCC via the PI3K/Akt pathway. Blockade of this pathway markedly attenuated CEP55-mediated proliferation, migration, invasion and epithelial-mesenchymal transition of ESCC cells. CONCLUSION: Oncogenic CEP55 correlates with a poor prognosis by regulating tumor cell proliferation, migration and invasion via the PI3K/Akt pathway. It can serve as a promising prognostic biomarker and therapeutic target of pN0 ESCC after Ivor-Lewis esophagectomy.
34
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Farin Kamangar, Graça M. Dores, William F. Anderson · Journal of Clinical Oncology · 2006 · 3.5K citations
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Florian Lordick, C. Mariette, Karin Haustermans et al. · Annals of Oncology · 2016 · 1.1K citations · Full text
Jack Cuzick, Gregory P. Swanson, Gabrielle Fisher et al. · The Lancet Oncology · 2011 · 811 citations · Full text